Cogent Biosciences Inc.

Cogent Biosciences Inc.

World Rank (Aug-2026)
2985
Market Cap (Aug-2026)
6.582 Billion USD
World Rank (Jan-05-2024)
12,548
Market Cap (Jan-05-2024)
0.504 Billion USD
World Rank (Jul-30-2023)
8,448
Market Cap (Jul-30-2023)
1.061 Billion USD
World Rank (Jan-07-2022)
16,133
Market Cap (Jan-07-2022)
0.332 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
COGT
Employee Count
138
Employee Count as of Date
As on 2022
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Operating Income in USD
-333 Million USD
Annual Net Income in USD
-329 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
938 Million USD
Total Liabilities in USD
301 Million USD
Total Equity in USD
636 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Company Website
COGENT BIOSCIENCES, INC.
Company Profile

Cogent Biosciences, Inc is a biotechnology company developing real solutions to treat genetically driven diseases. The headquarters is in USA.

Facts About Company

Cogent Biosciences, Inc Annual Net loss for year ending Dec-2022 was -140 million USD.

Cogent Biosciences, Inc Annual Net loss for year ending Dec-2021 was -72 million USD.

As on 2022, Cogent Biosciences, Inc has 138 employees.

IPO Year
2018
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share